Veradigm (MDRX) Concludes Exploration of Strategic Alternatives and Announces Operational Review
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/21/2026
- Wall St gains on chip stocks recovery; earnings draw focus
- Oil prices rise to five-week high on US-Iran attacks, Houthi blockade threat
- Chip stocks extend global rebound following last week's rout
- Citi's Chew says U.S. stock positioning unwind may not be over
- Adobe, Salesforce and Intuit fall as Morgan Stanley begins cautious coverage
- U.S. to impose 50% tariff on most Canadian goods, including USMCA
- Intersnack to acquire Utz Brands at $14.25 per share in go-private deal
- NVIDIA reports 9.3% passive stake in Nebius
- Wall Street indexes fall, with Iran and earnings season in focus
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
Veradigm Concludes Exploration of Strategic Alternatives and Announces Operational Review
January 30, 2025 4:02 PM ESTEngaged an Independent Strategic Advisor to Refine Go-Forward Plan
Company to Provide a Financial and Business Update in March
CHICAGO--(BUSINESS WIRE)-- Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that the Veradigm Board of Directors (the Board) completed its previously announced review of strategic alternatives to maximize... More
